Investorideas.com

Get investor ideas from our AI, cannabis, cleantech, crypto, gaming, mining, sports podcasts - be a guest or sponsor: call 800 665 0411


Share on StockTwits

Medterra to Broaden Horizons Under New Leadership

 

October 4, 2021 (Investorideas.com Newswire) Over the past few years, Medterra has become a leading name in the CBD industry in the United States, and also has operations in other parts of the world. In a few years alone, the company has grown to a turnover of $50 million per year, and it has enjoyed huge success with its wide range of high-quality CBD products sold at over 23,000 retail location in the United States and through thousands of distribution points across the globe.

Up until recently, the Managing Director for international operations was Gregory Reeder, and according to other senior executives, he helped to boost the success of international sales dramatically during his time as MD. However, Reeder has now been promoted to the Chief Executive Officer of Medterra, which was announced recently by the company.

Taking the Company in Other Directions

As the new CEO, Reeder has outlined many plans he has for the company, and he intends to take Medterra in other directions in addition to the CBD sector. Now that he is at the helm of the business, Reeder wants to broad the horizons of the brand by breaking into other health and wellness sectors. This will make a huge difference to its operations, turnover, success, and popularity with consumers.

Reeder is taking over from the previous CEO, Jay Hartenbach who will be the Chief Innovations Officer as well as Chairman of the Board. His strong background in product development and other executive roles within the pharmaceutical industry makes Reeder a great candidate for this position according to company officials.

Over the years, Reeder has worked for pharmaceutical giants including Pfizer and Proctor & Gamble, and he earned a Ph.D. in chemistry from the University of Cincinnati. His experience and expertise mean that he can make a valuable contribution to the direction the company now takes as it expands its offerings and moves into other areas in addition to CBD.

The former CEO of the company, Hartenbach, said, "Throughout his career, Greg has found continual success in accelerating the growth of both well recognized and newer brands. That experience is going to be critical to our efforts to expand as a company. Greg's success has only continued as he completely reshaped Medterra's international business. It was clear very early on that all of Medterra would benefit from this level of leadership."

In response, Reeder said that Hartenbach had been a great inspiration and had helped the company to achieve many great things. He said that the company had been envisioning expansion for a long time, and he intends to take it in the right direction.

With Medterra already having achieved great success, the appointment of Reeder as the CEO could see it go from strength to strength. The rising use and popularity of CBD have enabled Medterra to grow year upon year, thanks partly to its great range and excellent quality of its products. However, moving into other health and wellness industries as well will ensure that it enjoys an even wider audience and increased success as a result.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions.. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. This article is a third party guest post published content and not the content of Investorideas.com . Learn more about posting your articles at http://www.investorideas.com/Advertise/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp



About Investorideas.com

https://www.investorideas.com/About/

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp